The goals of our study were to compare the immune response to different killed and modified live vaccines against PRRS virus and to monitor the antibody production and the cell mediated immunity both at the systemic and local level. In the experiment, we immunized four groups of piglets with two commercial inactivated (A1-Progressis, A2-Suivac) and two modified live vaccines (B3-Amervac, B4-Porcilis). Twenty-one days after the final vaccination, all piglets, including the control non-immunized group (C5), were i.n., infected with the Lelystad strain of PRRS virus. The serum antibody response (IgM and IgG) was the strongest in group A1 followed by two MLV (B3 and B4) groups. Locally, we demonstrated the highest level of IgG antibodies in bronchoalveolar lavages (BALF), and saliva in group A1, whereas low IgA antibody responses in BALF and feces were detected in all groups. We have found virus neutralization antibody at DPV 21 (days post vaccination) and higher levels in all groups including the control at DPI 21 (days post infection). Positive antigen specific cell-mediated response in lymphocyte transformation test (LTT) was observed in groups B3 and B4 at DPV 7 and in group B4 at DPV 21 and in all intervals after infection. The IFN-γ producing lymphocytes after antigen stimulation were found in CD4-CD8+ and CD4+CD8+ subsets of all immunized groups 7 days after infection. After infection, there were obvious differences in virus excretion. The virus was detected in all groups of piglets in serum, saliva, and occasionally in feces at DPI 3. Significantly lower virus load was found in groups A1 and B3 at DPI 21. Negative samples appeared at DPI 21 in B3 group in saliva. It can be concluded that antibodies after immunization and infection, and the virus after infection can be detected in all the compartments monitored. Immunization with inactivated vaccine A1-Progressis induces high levels of antibodies produced both systemically and locally. Immunization with MLV-vaccines (Amervac and Porcilis) produces sufficient antibody levels and also cell-mediated immunity. After infection virus secretion gradually decreases in group B3, indicating tendency to induce sterile immunity.

Department of Immunology Veterinary Research Institute Brno Czechia

Department of Virology Veterinary Research Institute Brno Czechia

Faculty of Veterinary Medicine University of Veterinary and Pharmaceutical Sciences Brno Czechia

000      

00000naa a2200000 a 4500

001      

bmc20028851

003      

CZ-PrNML

005      

20210114155227.0

007      

ta

008      

210105s2019 sz f 000 0|eng||

009      

AR

024    7_

$a 10.3389/fimmu.2019.01689 $2 doi

035    __

$a (PubMed)31447829

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Toman, Miroslav $u Department of Immunology, Veterinary Research Institute, Brno, Czechia.

245    10

$a Dynamics and Differences in Systemic and Local Immune Responses After Vaccination With Inactivated and Live Commercial Vaccines and Subsequent Subclinical Infection With PRRS Virus / $c M. Toman, V. Celer, L. Kavanová, L. Levá, J. Frolichova, P. Ondráčková, H. Kudláčková, K. Nechvátalová, J. Salat, M. Faldyna,

520    9_

$a The goals of our study were to compare the immune response to different killed and modified live vaccines against PRRS virus and to monitor the antibody production and the cell mediated immunity both at the systemic and local level. In the experiment, we immunized four groups of piglets with two commercial inactivated (A1-Progressis, A2-Suivac) and two modified live vaccines (B3-Amervac, B4-Porcilis). Twenty-one days after the final vaccination, all piglets, including the control non-immunized group (C5), were i.n., infected with the Lelystad strain of PRRS virus. The serum antibody response (IgM and IgG) was the strongest in group A1 followed by two MLV (B3 and B4) groups. Locally, we demonstrated the highest level of IgG antibodies in bronchoalveolar lavages (BALF), and saliva in group A1, whereas low IgA antibody responses in BALF and feces were detected in all groups. We have found virus neutralization antibody at DPV 21 (days post vaccination) and higher levels in all groups including the control at DPI 21 (days post infection). Positive antigen specific cell-mediated response in lymphocyte transformation test (LTT) was observed in groups B3 and B4 at DPV 7 and in group B4 at DPV 21 and in all intervals after infection. The IFN-γ producing lymphocytes after antigen stimulation were found in CD4-CD8+ and CD4+CD8+ subsets of all immunized groups 7 days after infection. After infection, there were obvious differences in virus excretion. The virus was detected in all groups of piglets in serum, saliva, and occasionally in feces at DPI 3. Significantly lower virus load was found in groups A1 and B3 at DPI 21. Negative samples appeared at DPI 21 in B3 group in saliva. It can be concluded that antibodies after immunization and infection, and the virus after infection can be detected in all the compartments monitored. Immunization with inactivated vaccine A1-Progressis induces high levels of antibodies produced both systemically and locally. Immunization with MLV-vaccines (Amervac and Porcilis) produces sufficient antibody levels and also cell-mediated immunity. After infection virus secretion gradually decreases in group B3, indicating tendency to induce sterile immunity.

650    _2

$a zvířata $7 D000818

650    _2

$a protilátky virové $x biosyntéza $7 D000914

650    12

$a aktivace lymfocytů $7 D008213

650    _2

$a virus reprodukčního a respiračního syndromu prasat $x imunologie $7 D019316

650    _2

$a prasata $7 D013552

650    12

$a vakcinace $7 D014611

650    _2

$a inaktivované vakcíny $x imunologie $7 D015164

650    _2

$a živé neatenuované vakcíny $x imunologie $7 D062690

650    _2

$a virová nálož $7 D019562

650    _2

$a virové vakcíny $x imunologie $7 D014765

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Celer, Vladimir $u Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Brno, Czechia.

700    1_

$a Kavanová, Lenka $u Department of Immunology, Veterinary Research Institute, Brno, Czechia.

700    1_

$a Levá, Lenka $u Department of Immunology, Veterinary Research Institute, Brno, Czechia.

700    1_

$a Frolichova, Jitka $u Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Brno, Czechia.

700    1_

$a Ondráčková, Petra $u Department of Immunology, Veterinary Research Institute, Brno, Czechia.

700    1_

$a Kudláčková, Hana $u Department of Immunology, Veterinary Research Institute, Brno, Czechia.

700    1_

$a Nechvátalová, Kateřina $u Department of Immunology, Veterinary Research Institute, Brno, Czechia.

700    1_

$a Salat, Jiri $u Department of Virology, Veterinary Research Institute, Brno, Czechia.

700    1_

$a Faldyna, Martin $u Department of Immunology, Veterinary Research Institute, Brno, Czechia.

773    0_

$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 10, č. - (2019), s. 1689

856    41

$u https://pubmed.ncbi.nlm.nih.gov/31447829 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20210105 $b ABA008

991    __

$a 20210114155225 $b ABA008

999    __

$a ok $b bmc $g 1609186 $s 1120031

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2019 $b 10 $c - $d 1689 $e 20190806 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405

LZP    __

$a Pubmed-20210105